| Cancer | Prevalence-duration | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Two-year | Five-year | Ten-year | |||||||
| Both sexes | Males | Females | Both sexes | Males | Females | Both sexes | Males | Females | |
| All cancers | 675.2 | 694.5 | 656.2 | 1412.4 | 1,433.7 | 1391.6 | 2,248.1 | 2,219.8 | 2,275.8 |
| Oral cavity and pharynx | 16.2 | 22.1 | 10.3 | 33.6 | 45.4 | 22.1 | 54.1 | 73.1 | 35.3 |
| Esophagus | 3.8 | 5.7 | 1.9 | 5.5 | 8.3 | 2.8 | 7.0 | 10.3 | 3.8 |
| Stomach | 9.0 | 12.0 | 6.0 | 14.9 | 19.2 | 10.7 | 21.4 | 26.6 | 16.3 |
| Colorectal | 91.9 | 100.8 | 83.2 | 188.8 | 205.6 | 172.3 | 290.8 | 311.5 | 270.4 |
| Colon excluding rectum | 60.5 | 61.8 | 59.2 | 124.4 | 126.0 | 122.8 | 193.2 | 193.3 | 193.1 |
| Rectum and rectosigmoid | 31.5 | 39.0 | 24.1 | 64.4 | 79.5 | 49.5 | 97.6 | 118.2 | 77.3 |
| Anus | 2.7 | 2.4 | 3.0 | 5.4 | 4.6 | 6.2 | 8.3 | 7.0 | 9.6 |
| Liver | 2.9 | 4.5 | 1.4 | 4.8 | 7.4 | 2.3 | 6.1 | 9.2 | 3.0 |
| Pancreas | 5.7 | 5.5 | 5.8 | 7.6 | 7.5 | 7.7 | 9.4 | 9.2 | 9.7 |
| Larynx | 5.8 | 9.6 | 2.1 | 12.2 | 20.2 | 4.3 | 20.8 | 34.4 | 7.5 |
| Lung and bronchus | 54.8 | 57.7 | 52.0 | 86.0 | 88.7 | 83.3 | 115.6 | 119.6 | 111.6 |
| Soft tissue | 4.5 | 5.0 | 4.0 | 9.3 | 10.3 | 8.4 | 15.2 | 16.5 | 14.0 |
| Skin melanoma | 24.0 | 25.6 | 22.5 | 54.3 | 56.3 | 52.4 | 92.1 | 92.3 | 91.8 |
| Breast | 116.3 | 1.9 | 228.5 | 269.2 | 3.8 | 529.7 | 462.0 | 5.9 | 909.5 |
| Cervix uteri | … | … | 14.5 | … | … | 33.5 | … | … | 61.6 |
| Corpus uteri | … | … | 42.5 | … | … | 94.7 | … | … | 163.1 |
| Ovary | … | … | 20.2 | … | … | 38.6 | … | … | 57.6 |
| Prostate | … | 236.0 | … | … | 539.7 | … | … | 848.1 | … |
| Testis | … | 9.8 | … | … | 24.0 | … | … | 44.5 | … |
| Bladder (including in situ) | 32.8 | 49.9 | 15.9 | 68.1 | 103.3 | 33.5 | 111.4 | 167.2 | 56.6 |
| Kidney and renal pelvis | 18.8 | 22.8 | 14.9 | 39.9 | 48.2 | 31.8 | 63.9 | 76.6 | 51.4 |
| Brain | 6.6 | 7.7 | 5.5 | 11.9 | 13.7 | 10.3 | 18.7 | 21.1 | 16.4 |
| Thyroid | 18.7 | 7.7 | 29.5 | 40.7 | 17.6 | 63.4 | 63.8 | 27.8 | 99.2 |
| Hodgkin lymphoma | 5.0 | 5.5 | 4.5 | 11.7 | 13.1 | 10.3 | 21.5 | 23.9 | 19.1 |
| Non-Hodgkin lymphoma | 28.8 | 31.0 | 26.6 | 59.1 | 62.9 | 55.3 | 92.1 | 96.2 | 88.1 |
| Multiple myeloma | 7.9 | 8.6 | 7.2 | 14.2 | 15.2 | 13.2 | 18.4 | 19.6 | 17.1 |
| Leukemias | 18.0 | 21.5 | 14.6 | 35.8 | 42.2 | 29.5 | 55.0 | 63.9 | 46.3 |
| Other, unknown | 40.4 | 41.4 | 39.5 | 76.1 | 76.7 | 75.4 | 115.9 | 115.2 | 116.5 |
| Note: Prevalence proportions were determined by a tumour-based analysis. Source: Canadian Cancer Registry, Statistics Canada and Provincial/Territorial Cancer Registries. Table source: Statistics Canada, 2009, " Cancer prevalence in the Canadian population", Health Reports, Vol. 20, No. 1, catalogue number 82-003-X. |
|||||||||